Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-20
2005-09-20
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S257000
Reexamination Certificate
active
06946465
ABSTRACT:
Novel poly-substituted pteridinediones (lumazines), and mono- or polysubstituted 2-thiolumazines, 4-thiolumazines or 2,4-dithiolumazines, having disclosed substituents in positions 1, 3, 6 and 7 of the pteridine ring, and pharmaceutically acceptable salts thereof, being represented by the general formula (I).are useful as biologically active ingredients in preparing pharmaceutical compositions especially for the treatment or prevention of a CNS disorder, a cell proliferative disorder, a viral infection, an immune or auto-immune disorder or a transplant rejection. Combinations of the pteridine derivatives of the invention with an immunosuppressant or immunomodulator drug, an antineoplastic drug or an antiviral agent, providing potential synergistic effects, are also disclosed.
REFERENCES:
patent: 3071587 (1963-01-01), Curran et al.
patent: 3162635 (1964-12-01), Schroeder
patent: 5641783 (1997-06-01), Klein et al.
patent: 5843943 (1998-12-01), Carson et al.
patent: 0290189 (1998-11-01), None
patent: WO 94/06431 (1994-03-01), None
patent: WO 94/11001 (1994-05-01), None
patent: WO 9411001 (1994-05-01), None
patent: WO 94/22449 (1994-10-01), None
patent: WO 9422449 (1994-10-01), None
patent: WO 95/13075 (1995-05-01), None
patent: WO 9513075 (1995-05-01), None
patent: WO 95/31469 (1995-11-01), None
patent: WO 9531469 (1995-11-01), None
patent: WO 96/10568 (1996-04-01), None
patent: WO 9610568 (1996-04-01), None
patent: WO 96/20710 (1996-07-01), None
patent: WO 9620710 (1996-07-01), None
patent: WO 98/52948 (1998-11-01), None
patent: WO 9852948 (1998-11-01), None
patent: WO 00/45800 (2000-08-01), None
patent: WO 0045800 (2000-08-01), None
Cottam, H.B. et al, J. Med. Chem., 39(1), 2-9, 1996.
C. Robin Ganellin, “Final Report on the Activities of the Medicinal Chemistry Section”, [online]. Jan. 14, 2002 [retrieved on Jun. 2, 2004]. Ret'rieved from the Internet <www.iupac.org/divisions/VII/VII.M/ VIIM-ReportDec2001.pdf>.
Sugimoto, Takashi; Seo, Chihiro; Murata, Shizuaki; Pfleiderer, Wolfgang, Pteridines (1997), 8(3), 188-194.
Abou-Hadeed, Khaled; Pfleiderer, Wolfgang, Pteridines (1996), 7(4), 113-122.
Giori, P.; Poli, T.; Veronese, A. C.; Vicentini, C. B.; Manfrini, M.; Guarneri, M., Journal of Heterocyclic Chemistry, 23(6), 1661-5 (English) 1986.
Vinot, Nicole Bulletin de la Societe Chimique de France (1973), (9-10, Pt. 2), 2752-5.
Buu-Ho{hacek over (i )}et al., “Phthalonimides (1,3,4-Trioxo-1,2,3,4-tetrahydroisoquinolines) of Potential Biological Interest,” J. Heretocycl. Chem., 1968, 5:545-546.
Database Beilstein; accession nos. 285496, 252276, 250719, 1957.
Database Beilstein; accession nos. 533693, 540145, 1960.
Database Beilstein; accession nos. 6337777, 6373242, 1992.
Database Beilstein; accession no. 7216143, 1995.
Database Beilstein; accession no. 7928670, 1998.
Database Beilstein; accession nos. 9571456, 9570157, 2003.
Murata et al., “A Facile Method for Regioselective 6,7-disubstitution of Pteridine,” Heterocycles, 2000, 53:1259-1262.
Sato, et al., “Studies on Pyrazines. Part 37. Synthesis of 6-propionylpteridine-2, 4(1H, 3H)-dione and Its 1-and/or 3-methyl Derivatives from Marine Natural Products,” J. Chem. Soc., Perkin Trans. 2000, 1:89-95.
Cottam et al., “Substituted Xamthines, Pteridinediones, and Related Compounds ad Potential Antiinflammatory Agents. Synthesis and Biological Evaluation of Inhibitors of Tumor Necrosis Factor α,”J. Med. Chem., vol. 39, pp. 2-9, 1996.
Buu-Hoi et al., “Phthalonimides (1,3,4,Trioxo-1,2,3,4-tetrahydroisoquinolines) of Potential Biological Interest,”J. Heretocycl. Chem., vol. 5, No. 4, pp. 545-546, 1968.
Herdewijn Piet André Maurits Maria
Pfleiderer Wolfgang Eugen
Waer Mark Jozef Albert
4 AZA Bioscience NV
Clark & Elbing LLP
McKenzie Thomas C.
LandOfFree
Immunosuppressive effects of pteridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunosuppressive effects of pteridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunosuppressive effects of pteridine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3379802